A Single-Domain TCR-like Antibody Selective for the Qa-1b/Qdm Peptide Complex Enhances Tumoricidal Activity of NK Cells via Blocking the NKG2A Immune Checkpoint
- 1 May 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 208 (9) , 2246-2255
Abstract
The NKG2A/HLA-E axis is an immune checkpoint that suppresses immune effector activity in the tumor microenvironment. In mice, the ligand for the NKG2A/CD94 inhibitory receptor is the nonclassical MHC molecule Qa-1b, the HLA-E ortholog, which presents the peptide AMAPRTLLL, referred to as Qdm (for Qa-1 determinant modifier). This dominant peptide is derived from the leader sequences of murine classical MHC class I encoded by the H-2D and -L loci. To broaden our understanding of Qa-1b/Qdm peptide complex biology and its tumor protective role, we identified a TCR-like Ab from a single domain VHH library using yeast surface display. The TCR-like Ab (EXX-1) binds only to the Qa-1b/Qdm peptide complex and not to Qa-1b alone or Qa-1b loaded with control peptides. Conversely, currently available Abs to Qa-1b bind independent of peptide loaded. Flow cytometric results revealed that EXX-1 selectively bound to Qa-1b/Qdm-positive B16F10, RMA, and TC-1 mouse tumor cells but only after pretreatment with IFN-γ; no binding was observed following genetic knockdown of Qa-1b or Qdm peptide. Furthermore, EXX-1 Ab blockade promoted NK cell–mediated tumor cell lysis in vitro. Our findings show that EXX-1 has exquisite binding specificity for the Qa-1b/Qdm peptide complex, making it a valuable research tool for further investigation of the Qa-1b/Qdm peptide complex expression and regulation in healthy and diseased cells and for evaluation as an immune checkpoint blocking Ab in syngeneic mouse tumor models. Key Points A llama was immunized with Qa-1b/Qdm, ligand for NKG2A, to construct a VHH library. A single-domain TCR-like Ab, EXX-1, specific for Qa-1b/Qdm, was identified. EXX-1 selectively blocks the NKG2A/Qa-1b axis to promote NK lysis of target cells.Keywords
Funding Information
- The University of Texas Arlington (Start-up funds)
This publication has 50 references indexed in Scilit:
- Nanobodies: Natural Single-Domain AntibodiesAnnual Review of Biochemistry, 2013
- TCR-like Biomolecules Target Peptide/MHC Class I Complexes on the Surface of Infected and Cancerous CellsInternational Reviews of Immunology, 2011
- The nonpolymorphic MHC Qa-1b mediates CD8+ T cell surveillance of antigen-processing defectsJournal of Experimental Medicine, 2009
- Major histocompatibility complex (Mhc) class Ib gene duplications, organization and expression patterns in mouse strain C57BL/6BMC Genomics, 2008
- Critical Role of Qa1b in the Protection of Mature Dendritic Cells from NK Cell‐Mediated KillingScandinavian Journal of Immunology, 2007
- Regulation of Activated CD4+ T Cells by NK Cells via the Qa-1–NKG2A Inhibitory PathwayImmunity, 2007
- Extended presentation of specific MHC‐peptide complexes by mature dendritic cells compared to other types of antigen‐presenting cellsEuropean Journal of Immunology, 2004
- Recognition of the Class Ib Molecule Qa-1b by Putative Activating Receptors Cd94/Nkg2c and Cd94/Nkg2e on Mouse Natural Killer CellsJournal of Experimental Medicine, 1999
- Specific engagement of the CD94/NKG2-A killer inhibitory receptor by the HLA-E class Ib molecule induces SHP-1 phosphatase recruitment to tyrosine-phosphorylated NKG2-A: evidence for receptor function in heterologous transfectantsEuropean Journal of Immunology, 1998
- Identification of a tap-dependent leader peptide recognized by alloreactive T cells specific for a class Ib antigenCell, 1994